Evidence brief · printable

Vitiligo evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Vitiligo: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/vitiligo.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Ruxolitinib cream 6 trials
  • PF-06651600 5 trials
  • Ritlecitinib 3 trials
  • SHR0302Base gel 2 trials
  • Topical tacrolimus 0.1% ointment 2 trials
  • Upadacitinib 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Light and laser therapy (photobiomodulation) 20 trials · 10 completed · 5 with results
  • Vitamin D 2 trials · 2 completed · 0 with results
  • Psychotherapy, counselling and peer support 1 trials · 1 completed · 0 with results
  • Herbal medicines and traditional formulas 1 trials · 1 completed · 0 with results
  • Other behavioural interventions 1 trials · 1 completed · 0 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Ginkgo Biloba
  • Kutki
  • Phlebodium Aureum

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • A Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental… NCT07889492
  • A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in… NCT07431177
  • A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo NCT06625177
  • Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in… NCT07437560
  • PALLAS Laser for Skin Diseases NCT07250997
  • Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer… NCT07904910
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (23 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.